Progress against cardiovascular disease in the United States has slowed — and in some cases reversed — over the past 15 years ...

Scientists at Newcastle University have joined a new £50 million NIHR-funded national consortium aimed at tackling inequalities in cardiovascular disease.

Erectile dysfunction can indicate heart disease years before cardiovascular issues arise. In fact, most heart problems don’t ...

Cardiovascular disease is the leading cause of maternal death in the U.S., or more simply put, heart disease is the No. 1 ...

Global data show us that the impacts are far from marginal. The 2019 Global Burden of Disease analysis ranked hypertension as ...

What makes the current projections particularly troubling is that this increase is largely attributed to modifiable risk factors such as hypertension, obesity, diabetes, physical inactivity, and ...

Losing a battle you cannot see is one of the biggest challenges in medicine. And for many Americans, that quiet fight happens ...

Before the onset of cardiovascular disease symptoms, people often develop dyslipidemia, or abnormal levels of lipids in the blood. Recent studies suggest that microbes in the gut play an important ...

Prediabetes is a state where blood sugar levels are higher than normal but not high enough to qualify as type 2 diabetes. It ...

Erectile dysfunction can indicate heart disease years before cardiovascular issues arise. In fact, most heart problems don’t even start in the heart itself.

Researchers at Yale School of Medicine (YSM) are drawing attention to a powerful and preventable factor in cardiovascular disease. Their findings suggest that improving sleep may play a much ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).